MAPK7 anticorps (pThr218, pTyr220)
Aperçu rapide pour MAPK7 anticorps (pThr218, pTyr220) (ABIN2261968)
Antigène
Voir toutes MAPK7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 213-224, pThr218, pTyr220
-
Séquence
- C-HQYFMpTEpY VATR
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- ERK5, phosphorylated (Thr218, Tyr220) (Extracellular Signal-regulated Kinase 5, ERK-5, Big MAP Kinase 1, BMK1, BMK-1, Mitogen-activated Protein Kinase 7, MAP Kinase 7, MAPK 7, MAPK7, PRKM7)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- Synthetic peptide corresponding to aa213-224 from human Erk5 (C-HQYFM[pT]E[pY]VATR) (KLH). Species Sequence Homology: mouse (100%), rat (75%)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in 100 mM Tris-glycine, pH 7.4, 0.15M sodium chloride, 0.05 % sodium azide, 30 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- MAPK7 (Mitogen-Activated Protein Kinase 7 (MAPK7))
-
Autre désignation
- ERK5
-
Pathways
- Signalisation MAPK, Neurotrophin Signaling Pathway, Activation of Innate immune Response, cAMP Metabolic Process, Toll-Like Receptors Cascades, Negative Regulation of intrinsic apoptotic Signaling
Antigène
-